Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
68 Cards in this Set
- Front
- Back
Norepinephrine's action on the CNS
|
Effects learning, memory, sleep/wake cycle, mood & anxiety
Affective disorders/ADD |
|
Explain the effects of drug effects/side effects on the CNS (think about anti-depressants)
|
Over time there is an increase in the therapeutic effects
Over time the side effects tend to resolve |
|
What is tolerance?
|
When taking a drug that effects the CNS over a period of time the body needs more to produce the same therapeutic effects.
|
|
What is physical dependence?
|
When stopping a drug suddenly causes a withdrawal syndrome.
|
|
What are some changes in drug absorption in the elderly?
|
Increased gastric pH
Decreased absorptive surface area Deceased splanchnic (organ/intestinal) blood flow. Decreased GI motility Delayed gastric emptying |
|
What are some PO absorption considerations in infants?
|
1. Prolonged/irregular gastric emptying (absorption is unpredictable, can be increased or delayed)
2. Infants have lower gastric pH, so more acid drugs are more readily absorbed and basic drug absorption can possibly be delayed |
|
Pregnancy class A?
|
Remote risk of fetal harm
controlled studies show no harm in the first trimester, 2nd/3rd not tested. |
|
Pregnancy class B?
|
Slightly more risk than A
Animal studies show NO risk & no studies have been done in women. OR Animal studies show risk but studies in women (1st tri) show NO risk. (2nd/3rd tri.not tested) |
|
Pregnancy class C?
|
More risk than B
Animal studies may show risk & there have been no studies in women OR NO studies done in either animals or women (this is the class most drugs are in because the classification system was put in place AFTER many of the drugs were put on the market) |
|
Pregnancy class D
|
Proven fetal risk, but the benefits outweigh the risks. (asthma medications)
|
|
Pregnancy class X?
|
Proven fetal risk, benefits do not outweigh the risks (think accutane)
|
|
Changes in drug distribution in the elderly?
|
Increased body fat --> lipid soluble drugs are not distributed as efficiently because they are diffusing into the fat.
Decreased lean body mass + decreased H2O --> H2O soluble drugs have no where to diffuse so there is more free drug in the blood Low albumin Decreased CO |
|
Consideration for drug distribution in neonates/infants?
|
Low albumin
BBB not fully developed |
|
Changes in drug metabolism in the elderly?
|
Decreased metabolism --> increased half-life
Decreased first pass effects c PO medications |
|
Ach life cycle?
|
1. Released in response to action potential
2. Binds to nicotinic/muscarinic receptors 3. Disassociates from receptor 4. Degradation almost immediately by ach-esterase 5. By product of degradation choline reabsorbed to make Ach again |
|
Norepi. life cycle?
|
1. Released in response to action potiential
2. Binds to A1, A2, B1 3. disassociates 4. Re-uptake @ terminal 5. Stored in vesicles or degradation by monoaminoxidase (sp?) |
|
Epi life cycle?
|
1. Synthesis in the adrenal medulla
2. Norepi is released and converts to epi 3. TRAVELS IN THE BLOOD to target organs 4. Disassociates 5. METABOLIZED by liver |
|
B1 location & activation?
|
heart & kidneys
In the heart: Increases HR, increases contractility, and increased velocity @ the AV node. In the kidneys: Renin--agiotensin-aldosterone cascade BOTTOM LINE= INCREASED BP |
|
What is the MAIN reason for geriatric non-compliance?
|
The belief that the drug is not needed and/or causes side effects
|
|
Other reasons for geriatric non-compliance?
|
Forgetfulness
Failure to understand instruction $$ Complexity Multiple: chronic disorders, Rx, prescribers regimen changes living alone low literacy hospital discharge |
|
1. Selectivity of drugs that alter axonal conduction?
2. Why? 3. What type of drugs use axonal conduction? |
1. LOW selectivity
2. Drugs that alter axonal conduction will affect ALL nerves it has access to 3. Local anesthetics |
|
3 ways transmitters are removed from the synaptic gap?
|
1. Re-uptake by transport pump
2. Enzymatic degradation 3. Diffusion |
|
7 main CNS neurotransmitters?
|
Ach
Epi Norepi Dopamine Seritonin Histamine GABA |
|
3 basic patterns of autonomic regulation?
|
1. balance/opposition (as seen in the heart)
2. complementary (erection-pns/ejaculation-sns) 3. innervation and regulation of only ONE of the autonomic systems (blood vessels) |
|
5 step of synaptic transmission?
|
1. Transmitter synthesis
2 . " " storage 3. " " release 4. Receptor binding 5. Termination of transmission |
|
3 main function of SNS?
|
1. Regulation of CVS
2. Thermoregulation 3. Fight-Flight |
|
Ach action on the CNS?
|
excitatory
Ach is decreased with Alzheimer's Has influence on: attention/memory/mood/aggression/sleep/muscle tone/thirst/deference |
|
Epi action on the CNS?
|
low concentrations unlikely to play a role
|
|
Dopamine receptor function in SNS?
|
Dilate renal flood vessels
Increase cardiac contraction |
|
Dopamine receptor function in CNS?
|
The most important receptor in the CNS
Generally INHIBITORY hypothalamus, retina, limbic system, olfactory bulb, pituitary, cerebrum D1 & D2 subtypes Effects thoughts, emotions, movement, cognition/motivation |
|
B2 receptor function?
|
Broncho-dilation
Relaxing of uterine muscle (you want that Baby 2 stay in there) Increase Blood glucose vasodilation, in the heart/lungs/skeletal muscle VASODILATION...VASODILATION |
|
A1 Receptor function?
|
"I'M CONSTRICTING"
Ejaculation (Alpha male, is #1 and spreads his seeds) Contraction of bladder neck and prostate Constriction of skin mucous membranes Pupil dilation VASOCONSTRICTION |
|
A2 receptor function/location?
|
"STOP CONSTRICTING"
This receptor is located on the terminal end of the nerve itself NOT a target organ INHIBITS A1 Helps reduce transmitter release where there is too much in the synaptic gap VASODILATION |
|
Epi acts on what receptors?
|
A1, A2, B1, B2
|
|
Norepi act on what receptors?
|
A1, A2, B1
|
|
Dopamine acts on what receptors?
|
A1. B1, & dopamine receptors
|
|
Primary peripheral nervous system receptors and their sub-types?
|
Cholinergic: nicotinic(n&m), muscarinic
Adrenergic: A1, A2, B1, B2, dopamine |
|
What neurotransmitters do cholinergic receptors respond to?
|
Ach
|
|
What neurotransmitters do adrenergic receptors respond to?
|
Epi, norepi, dopamine
|
|
At what junctions is Ach the transmitter?
|
All preganglionic neurons
Postgang. neurons of the parasympathetic nervous system Sweat glands (only place Ach is postgang in the SNS) All skeletal muscle |
|
Nicotinic N receptor function?
|
Release of epi from adrenal medulla
|
|
Nicotinic M receptor function?
|
muscle contraction
|
|
How selective is synaptic transmission? how?
|
HIGHLY SELECTIVE, synapses at different sites employ different transmitters
|
|
Finish the sentence:
The impact of a drug on a neuronally regulated process is dependent on... |
the ability of the drug to influence receptor activity at the target cells
|
|
Three principal functions of the autonomic nervous system?
|
1. Regulation of the heart
2. Regulation of secretory glands 3. Regulation of smooth muscles |
|
Serotonin functions in CNS?
|
Most is in the brain stem
regulation of sleep/pain/depression/mood/sex/aggression/appetite/pain control/temp regulation |
|
Muscarinic 1-2-3 receptor function?
|
1. increased oral secretions, gastric acid and cognition
2. Decreased HR 3. Increased gladular secretions, pupil constriction, lens focus, bronchoconstriction, increased GI motility, erection |
|
Histamine's function in CNS?
|
Regulation of food/fluid intake, temperature, hormone release, sleep, allergic response mediation
|
|
Finish the sentence
Most nueropharmacologic agents act by___ |
altering synaptic transmission
|
|
Changes in drug excretion in the elderly?
|
Renal impairment/degeneration
|
|
What is the risk to a presomite when exposed to a teratogen?
|
If the dose is high enough (over lethal dose for presomite) = death
Usually if the dose is ANYTHING UNDER the lethal dose = generally no effects will be noticed |
|
What is the risk to an embryo when exposed to a teratogen?
|
Gross malformations, because the limbs are forming
|
|
What is the risk to a fetus when exposed to a teratogen?
|
The brain is affected. Learning and behavioral problems may be noted
|
|
Neonate (1) and infant (2) absorption of IM medications?
|
1. Neonate: slow, erratic
2. Infants: faster than adults |
|
Infant and neonate absorption of percutaneous medications?
|
Babies have thin skin, increased absorption
|
|
Drug metabolism in neonates/infants/children?
|
Neonates: metabolize SLOWER than adults
Infants: MUCH FASTER than adults age 2: sharp decline Puberty: gradual decline until another sharp decline at puberty when adult levels are reached. |
|
Division of the peripheral nervous system
|
A. Somatic motor
B Autonomic...PNS & SNS |
|
Renal excretion considerations in neonates/infants?
|
Slow excretion
|
|
At what age does drug absorption, distribution, and excretion reach adult levels?
|
ONE YEAR
|
|
At around what age does drug metabolism reach adult levels?
|
PUBERTY
|
|
Main ways drugs can effect receptor function and synaptic transmission
|
CAUSE receptor activation
BLOCK receptor activation Enhance receptor activation by the natural transmitter at the site |
|
Finish the sentence
The impact of a drug on a neuronally regulated process is _____ |
DEPENDENT on the ability of that drug to directly or indirectly influence receptor activity on target cells.
|
|
Lehne's definition of activation?
|
an effect on receptor function equivalent to that produced by the natural neurotransmitter at a particular synapse.
|
|
3 different effects drugs can have on transmitter synthesis?
|
1. Increased transmitter synthesis
2. Decreased transmitter synthesis 3. Cause the synthesis of transmitter molecules that are more effective than natural transmitters |
|
drugs that interfere with transmitter storage will cause?
|
Receptor activation to decrease. Because there is less neurotransmitter available.
|
|
How can drugs effect transmitter release?
|
Either promote or inhibit transmitter release
|
|
3 ways drugs can effect receptor binding?
|
1. Bind to receptor and cause activation (agonist)
2. Bind to receptor and block activation (antagonist) 3. Enhance the natural transmitter activation |
|
2 ways drugs can interfere termination of transmitter action?
|
1. Block reuptake (SSRI)
2.Inhibit transmitter degradation |